Cancers | Editor’s Choice Articles Published in 2024 and Special Issues in the “Cancer Drug Development” Section

We are delighted to share some of the most viewed papers in the “Cancer Drug Development” Section that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, a few Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that may be of interest to you.

The list of relevant papers can be seen below:

“Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs”
by Virginia Metrangolo and Lars H. Engelholm
Cancers 2024, 16(2), 447; https://doi.org/10.3390/cancers16020447
Available online: http://www.mdpi.com/2072-6694/16/2/447

“The Anticancer Application of Delivery Systems for Honokiol and Magnolol”
by Katarzyna Dominiak, Aleksandra Gostyńska, Michał Szulc and Maciej Stawny
Cancers 2024, 16(12), 2257; https://doi.org/10.3390/cancers16122257
Available online: https://www.mdpi.com/2072-6694/16/12/2257

“Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development”
by Whi-An Kwon, Seo-Yeon Lee, Tae Yoong Jeong, Hyeon Hoe Kim and Min-Kyung Lee
Cancers 2024, 16(13), 2420; https://doi.org/10.3390/cancers16132420
Available online: https://www.mdpi.com/2072-6694/16/13/2420

“The Microbiome Modulates the Immune System to Influence Cancer Therapy”
by Ruchi Roy and Sunil Kumar Singh
Cancers 2024, 16(4), 779; https://doi.org/10.3390/cancers16040779
Available online: https://www.mdpi.com/2072-6694/16/4/779

“Oligometastasis of Gastric Cancer: A Review”
by Itaru Yasufuku, Hiroshi Tsuchiya, Seito Fujibayashi, Naoki Okumura, Yuki Sengoku, Masahiro Fukada, Ryuichi Asai, Yuta Sato, Jesse Yu Tajima, Shigeru Kiyama et al.
Cancers 2024, 16(3), 673; https://doi.org/10.3390/cancers16030673
Available online: https://www.mdpi.com/2072-6694/16/3/673

Special Issues:

“Radiopharmaceuticals for Cancers” Guest Editors: Dr. Joseph Lau and Dr. Hwan Lee Submission deadline: 30 October 2025	“Advances in Drug Repurposing to Overcome Cancers” Guest Editor: Dr. Rafal Bartoszewski Submission deadline: 30 August 2025
“Research on New Drugs and Drug Targets in Melanoma” Guest Editors: Dr. Paula Wróblewska Łuczka and Dr. Nicolas Dumaz Submission deadline: 20 August 2025	“Development of Biomarkers and Antineoplastic Drugs in Solid Tumors” Guest Editors: Dr. Rosa Falcone, Dr. Sofia Verkhovskaia and Dr. Michela Roberto Submission deadline: 31 July 2025

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office